Healthtronics Inc

Healthtronics — Investor Presentation (February 2007)

27 slides from Healthtronics's investor presentation, Feb 14, 2007

  1. Slide 1: HealthTronics, Inc.

    Exhibit 99.1 HealthTronics, Inc. February 2007

  2. Slide 2: Forward-looking statements

    Statements in this presentation that are not strictly historical, including statements regarding plans, objective and future financial performance, are “forward-looking” statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Although

  3. Slide 3: Introduction

    Introduction Sam B. Humphries Became President and CEO of HealthTronics May, 2006 30 years in Medical Business GE AMS Venture Capital

  4. Slide 4: HealthTronics

    HEALTHTRONICS Based in Austin, Texas Public Company (NASDAQ: HTRN) World’s Largest Lithotripsy Service Provider Strong Profitable Partnership Model Access to Leading-Edge Technology Unique Business Relationship with One-Third of Urologists in the United States

  5. Slide 5: Urology Services

    Urology Services Map of US Sites

  6. Slide 6: We spent last half of 2006 restructuring and refocusing our business

    WE SPENT LAST HALF OF 2006 RESTRUCTURING AND REFOCUSING OUR BUSINESS Significant Reduction in Operating Expenses/Cost Exited Non-Strategic Businesses Sold Specialty Vehicle Business - $140M Entered New Strategic Segments One of Strongest Management Teams in the Business

  7. Slide 7: HealthTronics Leadership Team

    HEALTHTRONICS LEADERSHIP TEAM WORLD CLASS AND FOCUSED ON GROWTH (Organization Chart) Sam Humphries CEO James Whittenburg President Urology Services Ross Goolsby Chief Financial Officer Chris Schneider President Medical Products

  8. Slide 8: Current Business Units

    CURRENT BUSINESS UNITS Urology Services Lithotripsy Prostate Therapies Medical Products Products - - LithoDiamond ULTRA Lithotripter - - RevoLix Surgical Laser Service Maintenance Anatomical and Clinical Pathology

  9. Slide 9: Key Strategies

    KEY STRATEGIES Drive Growth and Profitability in our Core Lithotripsy Business Leverage the Power of our Business Relationship with One-Third of the Urologists in the United States We Are No Longer Just a Litho Company – We are a Premiere Urology Company Anything a Urologist Does Could be in Our Str

  10. Slide 10: US Market for Urology Products

    US MARKET FOR UROLOGY PRODUCTS (Chart) Category - 2005 Revenue (M) - Expected 5 Year CAGR Incontinence $610 8.6% BPH $240 11.8% Stone Management $230 6.4% Prostate Cancer $200 6.9% Scopes $190 6.6% ED $110 8.9% Access Products $60 8.0%

  11. Slide 11: Strategic Adjacency Segments

    STRATEGIC ADJACENCY SEGMENTS (Chart)

  12. Slide 12: Stone Management-Lithotripsy Market

    STONE MANAGEMENT-LITHOTRIPSY MARKET Total Market $230M Market - 6% CAGR 656K Procedures - 7% CAGR ESWL 387K Procedures - 2% CAGR Not Driven by Baby Boomers Multiple Treatment Methodologies ESWL Intracorpeal Lithotripsy Percutaneous Nephrolithotomy

  13. Slide 13: Prostate Therapy - BPH

    PROSTATE THERAPY - BPH Benign Prostatic Hyperplasia Non-Cancerous Enlargement of the Prostate Market Scope Affects 50% of Men Over Age 60 13M American Men in 2004 $650M - 12% CAGR Multiple Treatment Methodologies RevoLix Laser TUMT - Transurethral Microwave Therapy PVP GreenLight Surgery

  14. Slide 14: Prostate Therapy - Prostate Cancer

    PROSTATE THERAPY - PROSTATE CANCER Market Scope Second Most Common Cancer in American Males $5B Market 40M Males 230K New Cases Per Year 7% CAGR Dramatic Increase in Public Awareness Demanding Focal Therapy vs. Total Ablation Participating in the Diagnosis PSA Testing Anatomical Path Multi Treatment

  15. Slide 15: Urology Services - Lithotripsy

    UROLOGY SERVICES - LITHOTRIPSY Trusted Advisor to Urologist Partners Bring Value Added Products, Services and Benefits 62 Partnerships in 47 States ~130 Installed Lithotripsy Units ~3300 Physicians That Used HTRN Managed Devices During 2006 Unlimited Access to Technology

  16. Slide 16: Medical Products

    MEDICAL PRODUCTS Main Conduit for New Technologies Highest Growth Segments in Urology Manufacturing, Exclusive Distribution Products BPH – RevoLix Laser Lithotripsy – LithoDiamond ULTRA Services ClariPath Pathology Laboratory Maintenance Service

  17. Slide 17: Medical Products

    MEDICAL PRODUCTS US Installed Base: 190 HealthTronics Lithotripters 285 Lithotripters Under Maintenance (HealthTronics and Competitors) 22 RevoLix Lasers Pathology Lab Growing 10-15% Monthly

  18. Slide 18: Two Key Questions

    TWO KEY QUESTIONS How Will We Drive Growth? How Will We Drive Profitability?

  19. Slide 19: Urology Services

    UROLOGIY SERVICES Strategies to Drive Growth and Profitability WITHIN EXISTING PARTNERSHIPS NEW PARTNERSHIPS AND NEW PARTNERSHIP MODELS MARKET CONSOLIDATION

  20. Slide 20: Within Existing Partnerships

    WITHIN EXISTING PARTNERSHIPS Value Added Management Tools Unlimited Access to New Technologies Detailed Management of Utilization/Margins Drive Procedure Volume Marketing Low Cost Provider

  21. Slide 21: New Partnerships and Models

    NEW PARTNERSHIPS AND MODELS New Where Appropriate Competitive Partnerships New Technology - New Models RevoLix IMRT/IGRT

  22. Slide 22: Market Consolidation

    MARKET CONSOLIDATION HealthTronics Has 35% Market Share Nationwide Infrastructure Synergies Aggressive, Relentless But Disciplined

  23. Slide 23: Medical Products

    MEDICAL PRODUCTS Strategies to Drive Growth and Profitability Innovative Technology Service & Consumables ClariPath Pathology Lab

  24. Slide 24: Medical Products

    MEDICAL PRODUCTS Innovative Technology Launch of LithoDiamond Ultra Lithotripter “Game Changing” Equipment Dual Shock Source Expand RevoLix Laser Market Penetration - BPH Leading Edge Laser Technology Only System Providing Vaporization and Vaporesection Unequaled Physician Economic and Clinical Adva

  25. Slide 25: Medical Products

    MEDICAL PRODUCTS Services Expand Reach of our Pathology Laboratory - ClariPath Anatomical Pathology with Rapid Turn-Time and Exclusive Reporting Tools Provides Speed While Reducing Errors Project Doubling the Lab Size Within Six Months Expand Service Maintenance & Service Offering Only Service Organ

  26. Slide 26: Financials

    FINANCIALS Financial Impact of Restructuring Completed December, 2006 4Q Earnings to be Announced in Early March HealthTronics Has Not Provided Recent Guidance Strong Balance Sheet with Elimination of $120m of Long-Term Debt Strong Strategies in Place to Drive Growth and Productivity

  27. Slide 27: HealthTronics, Inc.

    HealthTronics, Inc. Feburary 2007 (Graphic of doctors)

HealthTronics — Investor Presentation (February 2007) on 6ix